PRECISIONBIOLOGICS
Menu
↗
PRECISION BIOLOGICS / LOCATIONS

Regenerative Biologics Supplier for Sarasota Pain Management Clinics

Precision Biologics distributes Wharton's jelly and exosome biologics to pain management and physical medicine practices in Sarasota, Florida through NPI-verified accounts. Shipments arrive with lot-specific documentation so a practice can maintain its own traceability records. Our team works directly with the practice's designated point of contact to set up and verify an account before the first order ships.

Vendor qualification in multi-disciplinary pain practices

Pain management and physical medicine practices frequently involve more than one credentialed provider, so vendor review often sits with a practice administrator who then routes the final decision to a supervising physician or medical director. That review typically asks for the same core documents regardless of practice size: a certificate of analysis for the specific lot being ordered, a summary of donor eligibility screening, and a description of how the product was processed and tested before release. Practices that bill through multiple provider NPIs under one group often designate a single ordering contact to keep the vendor relationship and lot records consistent.

REGISTRY DATA / FL

Sarasota

NPPES registry listings, primary taxonomy, retrieved 2026-10-27

103
Pain Medicine
47
Physical Medicine & Rehabilitation
56
Source: NPPES NPI Registry ↗

Setting up an NPI-verified account

Account approval requires a National Provider Identifier, and Precision Biologics limits orders to licensed professionals. A Sarasota practice with both Pain Medicine and Physical Medicine & Rehabilitation providers on staff should decide at setup which NPI the account will be registered under, since that is the identifier tied to every subsequent order and lot record.

Receiving shipments and holding documentation

Cryopreserved products ship overnight on dry ice in validated containers and should go straight into -80 C storage on arrival; lyophilized products ship shelf-stable and store at room temperature per the insert in that lot. Either way, the practice's receiving staff should log the lot number against the delivery date immediately, since that log is what ties a specific vial back to its certificate of analysis if the practice is ever asked to produce records.

  • Confirm lot number against the packing slip on arrival
  • Place cryopreserved vials into -80 C storage immediately
  • File the certificate of analysis with the practice's own procurement records

Regulatory review and ongoing support

Florida practices should confirm their own regulatory posture with the Florida Board of Medicine and independent counsel rather than relying on a supplier's description; Florida's SB 1768, in effect since July 1, 2025, covers physician use of certain non-FDA-approved stem cell therapies in orthopedics, wound care, and pain management under informed consent, but it does not substitute for federal FDA requirements that apply to the products themselves. Precision Biologics supports that review by providing registration and licensure documentation on request and by connecting a requesting physician with a peer for a documentation-focused call, not clinical advice.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.

FAQ

Frequently asked questions

Can a practice order under one NPI if it has both pain medicine and physical medicine providers?+

Yes. The account is registered to a single verified NPI, which the practice designates at setup; that identifier is tied to every order.

What should a Sarasota pain practice do with cryopreserved shipments on arrival?+

Log the lot number against the packing slip, then move cryopreserved vials into -80 C storage immediately. The certificate of analysis for that lot should be filed with the receiving record.

Does Precision Biologics advise on clinical use for pain management?+

No. We provide product documentation and account support. Clinical use decisions belong to the treating physician and their own regulatory counsel.